Deleted Tweets From Scott Gottlieb, R-D.C.

RT @steveusdin1: FDA to hold patient meeting on opioid use disorder. This will be powerful and important. https://t.co/bp2ASUjdPV

For our Patient Focused Drug Development meeting on opioids; we’re interested in patient views on: The impact opioid use disorder has health & well-being/daily life; experience w/ prescription & other treatments; challenges/barriers to accessing/u

BioCentury analysis of #FDA’s new initiatives in the @POTUS budget via @steveusdin1 https://t.co/0XixgPifTD

Adults can’t favor preserving properly regulated e-cigarettes as an alternative for smokers who quit combustible tobacco, and not at same time vigorously oppose child access to e-cigs. The industry isn’t sustainable if it leads to a whole generation of yo

An analysis by BioCentury of the proposal from #FDA for new medical product initiatives —contained in the FY2019 budget — to foster new drug/device innovation; generic competition; economic growth; domestic industries; and manufacturing advances by @steve

RT @RareDiseases: Yesterday, Dr. Scott Gottlieb, Commissioner of @US_FDA released a statement on advancing development of novel new t… https://t.co/rbbWlaxqp8

RT @CDCgov: #Whoopingcough is serious and sometimes deadly for young babies. Parents, learn more about how everyone can help pr… https://t.co/IkEaSa7tdq

#FDA is holding a Patient-Focused Drug Development meeting in April to allow individuals with opioid use disorder bring their voice to #FDA & the drug development process. Help make this meeting a success by signing up to participate: https://t.co/VA9

My @KHNews interview: “There are ‘situations where you see deals cut’ in which a drugmaker will get 180-day exclusivity and then be persuaded to sit on it without ever selling the drug, essentially delaying the brand drug from facing generic competition.”

#FDA will be updating this week on our analysis of the increased efficacy we saw against H3N2 this #flu season from vaccines manufactured in cells vs those made through the egg based process. The reasons for this differential may help us prepare better fo

In 2 weeks, #FDA convenes its advisory panel to help select strains for next season’s flu vaccines; and will discuss this cell vs egg data. It takes several months to produce flu vaccines; strains for next season must be selected before current season end

I joined HHS @SecAzar and my public health colleagues for an update on the #flu https://t.co/TvWRvdwSgP https://t.co/a82tMMlj1n

Modern, safe and effective vaccines are one of humanity’s greatest achievements - and the commitment of @WHO @gatesfoundation @US_FDA and many others to extend these opportunities to lower income countries among our most important global public health obl QT @Health_Affairs: Modeling the impact of #vaccines on averting deaths & reducing poverty in 41 low- and middle-income countries… https://t.co/GEVYtkKcvi)

3/3 The new minimum performance requirements #FDA implemented for the antigen-based #flu tests are expected to lower the number of misdiagnosed influenza infections by promoting the development of new, improved devices that can more reliably detect the in

1/3 There are reports by certain media that some of the older antigen-based rapid flu tests are not as accurate as newer tests. This is why #FDA reclassified the older tests and established special controls that include minimum performance levels.

Manufacturers had until Jan 12, 2018 to come into compliance. Of additional note, #CDC guidelines and #FDA both recommend that clinical decisions be made based on signs and symptoms consistent with the #flu and not simply rely on a test, even an accurate

“As the overdose epidemic shifted from overprescribing of short-acting prescription opioids to cheaper and more dangerous alternatives such as illicit fentanyl... FDA is looking to the internet... to identify new problems before they spiral out of control

RT @PharmaPinkSheet: #Alzheimers Biomarkers Gain Prominence In Drug Development Guidance https://t.co/qSeUv51xdO https://t.co/CYYauGxN7P

RT @gavi: This flu season, @CDCgov have found children ages 6 months � to 8 years �� responded significantly better to the US… https://t.co/LIzPDz49uj

“Although the data are limited, they do suggest that gabapentinoid abuse and misuse ‘may be growing, both [when] taken alone and in combination with opioid, benzodiazepines, or other central nervous system depressants,’ Gottlieb said https://t.co/FhDbBv1a

RT @steveusdin1: FDA to hold patient meeting on opioid use disorder. This will be powerful and important. https://t.co/bp2ASUjdPV

For our Patient Focused Drug Development meeting on opioids; we’re interested in patient views on: The impact opioid use disorder has health & well-being/daily life; experience w/ prescription & other treatments; challenges/barriers to accessing/u

BioCentury analysis of #FDA’s new initiatives in the @POTUS budget via @steveusdin1 https://t.co/0XixgPifTD

Adults can’t favor preserving properly regulated e-cigarettes as an alternative for smokers who quit combustible tobacco, and not at same time vigorously oppose child access to e-cigs. The industry isn’t sustainable if it leads to a whole generation of yo

An analysis by BioCentury of the proposal from #FDA for new medical product initiatives —contained in the FY2019 budget — to foster new drug/device innovation; generic competition; economic growth; domestic industries; and manufacturing advances by @steve

RT @RareDiseases: Yesterday, Dr. Scott Gottlieb, Commissioner of @US_FDA released a statement on advancing development of novel new t… https://t.co/rbbWlaxqp8

RT @CDCgov: #Whoopingcough is serious and sometimes deadly for young babies. Parents, learn more about how everyone can help pr… https://t.co/IkEaSa7tdq

#FDA is holding a Patient-Focused Drug Development meeting in April to allow individuals with opioid use disorder bring their voice to #FDA & the drug development process. Help make this meeting a success by signing up to participate: https://t.co/VA9

My @KHNews interview: “There are ‘situations where you see deals cut’ in which a drugmaker will get 180-day exclusivity and then be persuaded to sit on it without ever selling the drug, essentially delaying the brand drug from facing generic competition.”

#FDA will be updating this week on our analysis of the increased efficacy we saw against H3N2 this #flu season from vaccines manufactured in cells vs those made through the egg based process. The reasons for this differential may help us prepare better fo

In 2 weeks, #FDA convenes its advisory panel to help select strains for next season’s flu vaccines; and will discuss this cell vs egg data. It takes several months to produce flu vaccines; strains for next season must be selected before current season end

I joined HHS @SecAzar and my public health colleagues for an update on the #flu https://t.co/TvWRvdwSgP https://t.co/a82tMMlj1n

Modern, safe and effective vaccines are one of humanity’s greatest achievements - and the commitment of @WHO @gatesfoundation @US_FDA and many others to extend these opportunities to lower income countries among our most important global public health obl QT @Health_Affairs: Modeling the impact of #vaccines on averting deaths & reducing poverty in 41 low- and middle-income countries… https://t.co/GEVYtkKcvi)

3/3 The new minimum performance requirements #FDA implemented for the antigen-based #flu tests are expected to lower the number of misdiagnosed influenza infections by promoting the development of new, improved devices that can more reliably detect the in

1/3 There are reports by certain media that some of the older antigen-based rapid flu tests are not as accurate as newer tests. This is why #FDA reclassified the older tests and established special controls that include minimum performance levels.

Manufacturers had until Jan 12, 2018 to come into compliance. Of additional note, #CDC guidelines and #FDA both recommend that clinical decisions be made based on signs and symptoms consistent with the #flu and not simply rely on a test, even an accurate

“As the overdose epidemic shifted from overprescribing of short-acting prescription opioids to cheaper and more dangerous alternatives such as illicit fentanyl... FDA is looking to the internet... to identify new problems before they spiral out of control

RT @PharmaPinkSheet: #Alzheimers Biomarkers Gain Prominence In Drug Development Guidance https://t.co/qSeUv51xdO https://t.co/CYYauGxN7P

RT @gavi: This flu season, @CDCgov have found children ages 6 months � to 8 years �� responded significantly better to the US… https://t.co/LIzPDz49uj

“Although the data are limited, they do suggest that gabapentinoid abuse and misuse ‘may be growing, both [when] taken alone and in combination with opioid, benzodiazepines, or other central nervous system depressants,’ Gottlieb said https://t.co/FhDbBv1a